Partner Jim Abbott is quoted and the Firm is mentioned in a Pharmawire article on the potential acquisition of Talecris by a company from another industry.
June 18, 2009
Pharmawire
Jim Abbott comments on the difficulty of small companies like potential buyer Octapharma to obtain external financing.
Related Attorneys
![](https://www.sewkis.com/wp-content/uploads/Abbott_Thumbnail@2x-96x108-c-default.png)
James E. Abbott
(212) 574-1226
abbott@sewkis.com